FTH
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. (FTH) has 6 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 1, 2026.
The most active filer is Chief Financial Officer STEPHENSON BRIAN C with 7 filings. Insiders have net bought $1.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Anand Parikh
- Employees:29
- HQ:Rockville, MD, US
- IPO:2014-08-11
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$32.9M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Financial Officer | Purchase | 831 | $19K | Jul 1 | SEC ↗ | |
| Chief Financial Officer | Purchase | 7,803 | $189K | Jul 1 | SEC ↗ | |
| Chief Financial Officer | Purchase | 5,000 | $117K | Jul 1 | SEC ↗ | |
| Chief Financial Officer | Purchase | 9,391 | $245K | Jun 26 | SEC ↗ | |
| Chief Financial Officer | Purchase | 6,250 | $156K | Jun 26 | SEC ↗ | |
STEPHENSON BRIAN CFirst filing | Chief Financial Officer | Purchase | 8,183 | $181K | Jun 24 | SEC ↗ |
STEPHENSON BRIAN CFirst filing | Chief Financial Officer | Purchase | 9,230 | $225K | Jun 24 | SEC ↗ |
Parikh Anand KiranFirst filing | President and CEO | Purchase | 2,806 | $55K | Jun 24 | SEC ↗ |
Related companies
Faeth Therapeutics, Inc. is in the Healthcare sector.